Patient must have valid Social Security number to apply for assistance and receive treatment in the United States.
Patient income must be at or below 500% of the Federal Poverty Level (FPL.)
Patient is required to have insurance coverage which covers at least 50% of the cost of treatment.
Patient must be diagnosed with a covered disease and program must be accepting enrollments.
Patient must be seeking assistance for a prescribed medication that is FDA approved to treat the covered diagnosis.
Evrysdi
Prednisolone
Spinraza
Zolgensma
Spinal muscular atrophy (SMA) is a group of hereditary diseases that progressively destroys motor neurons—nerve cells in the brain stem and spinal cord that control essential skeletal muscle activity such as speaking, walking, breathing, and swallowing, leading to muscle weakness and atrophy. (Source: National Institute of Neurological Disorders and Stroke; Spinal Muscular Atrophy Fact Sheet)
Eligibility Criteria
Patient must have valid Social Security number to apply for assistance and receive treatment in the United States.
Patient income must be at or below 500% of the Federal Poverty Level (FPL.)
Patient is required to have insurance coverage which covers at least 50% of the cost of treatment.
Patient must be diagnosed with a covered disease and program must be accepting enrollments.
Patient must be seeking assistance for a prescribed medication that is FDA approved to treat the covered diagnosis.
Medications Covered
Evrysdi
Prednisolone
Spinraza
Zolgensma
Disease Description
Spinal muscular atrophy (SMA) is a group of hereditary diseases that progressively destroys motor neurons—nerve cells in the brain stem and spinal cord that control essential skeletal muscle activity such as speaking, walking, breathing, and swallowing, leading to muscle weakness and atrophy. (Source: National Institute of Neurological Disorders and Stroke; Spinal Muscular Atrophy Fact Sheet)